Imperva Management Says Longer Sales Cycles To Blame For Poor Q2 Results By: Benzinga via Benzinga July 13, 2016 at 10:05 AM EDT Imperial Capital’s Michael Kim believes investors are likely to remain cautious on Imperva Inc (NYSE: IMPV) in the near term, ... Read More >> Related Stocks: Bio-Techne Corp